Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/24 18:11 | 1/22/24 | RYZB | Health | Drug | Pharmaceutical Preparations | Moran Susan | CA | O | Chief Me | M.d | 100 | 3.24 | 0 | 31 | 11 | 323 | D | ||||||||||||||
9/21/23 17:10 | 9/19/23 | RYZB | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | P.d | 8,500 | 18.00 | 0 | 472 | 64 | 1,210 | I | |||||||||||||||
9/21/23 17:00 | 9/19/23 | RYZB | Health | Drug | Pharmaceutical Preparations | Viking Global Investors LP | CT | T | P.d | 25,000 | 18.00 | 0 | 1,389 | 392 | 1,744 | I | |||||||||||||||
9/21/23 16:59 | 9/19/23 | RYZB | Health | Drug | Pharmaceutical Preparations | Viking Global Investors LP | CT | T | P.d | 25,000 | 18.00 | 0 | 1,389 | 392 | 1,744 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |